Codes / ICD10CM / H16.409

H16.409 Unspecified corneal neovascularization, unspecified eye

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Unspecified corneal neovascularization, unspecified eye

Summary

Unspecified corneal neovascularization, unspecified eye, refers to the abnormal growth of blood vessels onto the cornea of an unspecified eye without further specification of the underlying cause. This condition can impair vision and may result from various factors, including inflammation, injury, or ocular diseases. Evaluation is necessary to determine the cause and appropriate management.

Causes

Corneal neovascularization can be triggered by inflammation, infection, or injury to the cornea. Common causes include chronic dry eye, contact lens wear, ocular surgery, or conditions like uveitis. It may also develop secondary to corneal edema, chemical burns, or autoimmune disorders affecting the eye.

Risk Factors

  • Prolonged contact lens use, especially with poor hygiene.
  • History of eye trauma or surgery.
  • Chronic ocular inflammation or infection.
  • Underlying systemic conditions like diabetes or autoimmune diseases.
  • Use of topical medications that disrupt corneal health.

Symptoms

  • Blurred or reduced vision.
  • Eye redness or irritation.
  • Sensitivity to light (photophobia).
  • A feeling of a foreign object in the eye.
  • Visible blood vessels on the cornea (may be observed during exam).

Diagnosis

Diagnosis involves a comprehensive eye exam, including slit-lamp microscopy to assess the cornea and surrounding structures. Additional tests, such as fluorescein angiography or corneal topography, may be used to evaluate the extent of neovascularization and rule out other conditions. A thorough patient history is essential to identify potential underlying causes.

Treatment Options

Treatment focuses on addressing the underlying cause and reducing neovascularization. Options may include topical anti-inflammatory medications, lubricating eye drops, or contact lens modifications. In severe cases, surgical interventions like corneal transplantation or laser therapy may be considered. Management should be tailored to the individual patient's condition and needs.

Prognosis and Follow-Up

Prognosis depends on the underlying cause and severity of the neovascularization. Early intervention can improve outcomes, but some cases may lead to permanent vision changes. Regular follow-up with an eye care professional is necessary to monitor progression and adjust treatment as needed.

Complications

Complications may include reduced visual acuity, corneal scarring, or increased risk of infection. Severe cases can lead to corneal opacity or perforation, requiring more aggressive treatment.

Lifestyle & Prevention

  • Maintain good eye hygiene, especially with contact lens use.
  • Protect the eyes from injury or chemical exposure.
  • Manage underlying conditions like diabetes or autoimmune diseases.
  • Use lubricating eye drops as recommended to prevent dryness.
  • Avoid smoking, which can worsen ocular inflammation.

When to Seek Professional Help

Seek immediate medical attention if you experience sudden vision loss, severe eye pain, or increased redness. Regular eye exams are recommended for early detection of corneal changes, especially if you have risk factors like contact lens use or a history of eye trauma.

Tips for Medical Coders

When coding H16.409, ensure the documentation specifies "unspecified corneal neovascularization" and "unspecified eye" to match the code's description. Verify that no laterality (e.g., right or left eye) is documented, as this would require a different code. Confirm that the diagnosis is not further specified by cause, as this code is intended for unspecified etiology.

Book a walkthrough

H16.409 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.